VANGUARD GROUP INC - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 26 filers reported holding ACER THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$386,387
+0.8%
474,094
+14.2%
0.00%
Q2 2023$383,271
+21.7%
415,0650.0%0.00%
Q1 2023$314,827
-62.9%
415,065
+22.7%
0.00%
Q4 2022$849,319
+119.5%
338,374
+21.4%
0.00%
Q3 2022$387,000
+9.6%
278,634
-0.6%
0.00%
Q2 2022$353,000
-56.3%
280,419
+0.8%
0.00%
Q1 2022$807,000
+97.8%
278,215
+55.5%
0.00%
Q4 2021$408,000
-12.3%
178,880
-1.6%
0.00%
Q3 2021$465,000
-9.2%
181,740
+1.4%
0.00%
Q2 2021$512,000
-2.1%
179,143
+6.6%
0.00%
Q1 2021$523,000
+73.8%
168,049
+46.0%
0.00%
Q4 2020$301,000
-15.0%
115,103
-6.4%
0.00%
Q3 2020$354,000
-26.7%
123,027
-12.8%
0.00%
Q2 2020$483,000
+42.9%
141,027
-16.8%
0.00%
Q1 2020$338,000
-50.2%
169,548
+0.2%
0.00%
Q4 2019$679,000
+25.7%
169,292
-0.1%
0.00%
Q3 2019$540,000
-50.2%
169,390
-39.1%
0.00%
Q2 2019$1,084,000
-83.1%
277,963
+5.4%
0.00%
Q1 2019$6,406,000
+26.7%
263,626
+4.9%
0.00%
Q4 2018$5,057,000
-32.8%
251,329
+3.0%
0.00%
Q3 2018$7,526,000
+2750.8%
244,033
+1898.5%
0.00%
Q2 2018$264,000
+14.3%
12,2110.0%0.00%
Q1 2018$231,00012,2110.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders